Type2 Diabetes patients with medication non-adherence Medication adherence Type2 Diabetes Mobile application
Conditions
Interventions
Patients in the intervention group will receive medication reminders through a mobile application combined with the usual care at the diabetes clinic,Patients in the control group will receive the usu
Experimental Device,No Intervention No treatment
Mobile application,Usual diabetic care
Sponsors
Faculty of Medicine, Ramathibodi Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients above the age of 18 years with diabetes type 2 2. Fasting blood sugar >= 130 mg/dL or HbA1C) >= 7% 3. On oral hypoglycemic agents for at least 6 months 4. Could use mobile phone and mobile application 5. Able to comprehend Thai 6. Pre-test Medication Adherence Scale in Thais or MAST less than 34 scores
Exclusion criteria
Exclusion criteria: 1. Diagnosed mild cognitive impairment or dementia 2. Could not use mobile phones or mobile application 3. Patients who received insulin and glucagon-like peptide-1 (GLP-1) 4. Pregnant 5. Using 1 or more of the following medications that can affect blood sugar in 3 months -Thiazide diuretics -Beta blocker: Propanolol, Nadolol -Antipsychotic: clonazepam, olanzapine -Glucocorticoids -Fluoroquinolones: Ciprofloxacin, Levofloxacin, Ofloxacin -Antiprotozoal/Antifungals: Pentamine -Protease inhibitor: Ritonavir, Nelfinavir, Indinavir -Nucleoside reverse transcriptase inhibitors: Didanosine, Abacavir - Phosphodiesterase inhibitor: Theophylline
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Medication adherence at the end of intervention Patient reported outcome using a Medication adherence scale in Thais | — |
Secondary
| Measure | Time frame |
|---|---|
| HbA1C at the end of intervention Blood test,Fasting blood sugar at the end of intervention Blood test | — |
Countries
Thailand
Contacts
Public ContactKanyapha Chanjiragitti
Mahidol University
Outcome results
None listed